| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,808 |
11,290 |
$536K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,147 |
3,605 |
$152K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
929 |
758 |
$54K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
612 |
535 |
$51K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,684 |
610 |
$48K |
| 93970 |
|
514 |
433 |
$48K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,773 |
639 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,393 |
1,219 |
$24K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,372 |
531 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
243 |
226 |
$21K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
305 |
245 |
$14K |
| 73630 |
|
517 |
357 |
$8K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
932 |
776 |
$4K |
| 99152 |
|
147 |
119 |
$4K |
| 64483 |
|
42 |
39 |
$4K |
| 20610 |
|
101 |
85 |
$2K |
| 73564 |
|
58 |
43 |
$2K |
| 20611 |
|
30 |
26 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$2K |
| 20553 |
|
69 |
57 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
149 |
112 |
$1K |
| 64493 |
|
13 |
12 |
$1K |
| 72110 |
|
42 |
39 |
$1K |
| 99215 |
Prolong outpt/office vis |
19 |
16 |
$948.75 |
| 73030 |
|
30 |
27 |
$808.73 |
| 64494 |
|
13 |
12 |
$592.76 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
27 |
25 |
$588.30 |
| 81000 |
|
649 |
535 |
$392.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
364 |
312 |
$321.52 |
| 20550 |
|
15 |
12 |
$103.04 |
| 96127 |
|
18 |
18 |
$36.98 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
20 |
15 |
$4.49 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
15 |
14 |
$1.01 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
20 |
12 |
$0.10 |